Continuous glucose monitoring systems for monitoring cystic fibrosis-related diabetes

CONCLUSIONS: No studies were included in the review, indicating that there is currently insufficient evidence to determine the impact of insulin therapy guided by CGMS compared to insulin therapy guided by other forms of glucose data collection on the lives of people with CFRD, nor on potential adverse effects of continuous glucose monitoring in this context. Randomised controlled studies are needed to generate evidence on the efficacy and safety of continuous glucose monitoring in people with CFRD. There is one relevant ongoing study that may be eligible for inclusion in a future update of this Cochrane Review, and whose results may help answer the review question.PMID:34844283 | DOI:10.1002/14651858.CD013755.pub2
Source: Cochrane Database of Systematic Reviews - Category: General Medicine Authors: Source Type: research